SCHEMBL20910722

SCHEMBL20910722

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c(-c2cc(C(F)(F)F)ccc2-n2c3ccccc3c3cc(C)ccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 4/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ KIF11 P52732 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ ABCG2 Q9UNQ0 4/20 0.33
▸ PDE2A O00408 1/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ TDO2 P48775 1/20 0.32
▸ IDO2 Q6ZQW0 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ TEAD1 P28347 1/20 0.32
▸ TEAD4 Q15561 1/20 0.32
▸ TEAD2 Q15562 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20910724 0.97 CYP1A2 (0.35) PPARGPPARAKIF11CYP1A2CYP3A4
SCHEMBL20910990 0.94 DHODH (0.34) PPARGPPARAKIF11CYP1A2CYP3A4
SCHEMBL20911036 0.93 PPARG (0.36) PPARGPPARAKIF11ABCG2LMNA
SCHEMBL20910849 0.93 PPARG (0.33) PPARGPPARAKIF11CYP1A2CYP3A4
SCHEMBL20910988 0.93 PPARG (0.35) PPARGPPARAKIF11ABCG2MAT2A
SCHEMBL20902598 0.92 PPARG (0.35) PPARGPPARAKIF11ABCG2LMNA
SCHEMBL21090393 0.91 KIF11 (0.39) KIF11CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL20910844 0.91 PPARG (0.33) PPARGPPARAKIF11ABCG2PDE2A
SCHEMBL20911035 0.91 KIF11 (0.36) PPARGPPARAKIF11CYP1A2CYP2C9
SCHEMBL20910897 0.90 LMNA (0.37) PPARGPPARACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10998504-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-05-04 — — US disclosed
US-20190115544-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-04-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10998504-B2 Organic molecules for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 PPARG 651/4885PPARA 1252/4885KIF11 451/4885
US-20190115544-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OCIAD1, OCIAD2, POU2F1 PPARG 651/4885PPARA 1252/4885KIF11 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback